|
Real-time Estimate
Cboe BZX
22:27:48 21/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.6710 USD | -4.13% |
|
-9.00% | -3.09% |
| 09-17 | WINNERS & LOSERS: Alkemy Capital gets grant; OptiBiotix loss widens | AN |
| 09-16 | Aterian Plans Capital Raise to Fund Tungsten Trading Trial | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.13% | -9.00% | +54.80% | -48.94% | -3.09% | -32.07% | -81.92% | -99.57% | - | 11.43M | |
| +0.16% | -3.30% | -5.67% | -10.33% | -1.91% | -10.07% | -24.88% | - | - | 573M | |
| -1.12% | +0.23% | +0.69% | +5.77% | +8.37% | +10.83% | +9.45% | -8.52% | +13.11% | 356M | |
| -0.69% | +1.42% | -4.79% | -4.28% | -1.65% | +4.07% | +33.58% | +60.25% | +125.87% | 278M | |
| +4.76% | +2.80% | -4.35% | +20.22% | +125.41% | +47.65% | -20.29% | -74.42% | +6.80% | 257M | |
| 0.00% | 0.00% | -0.95% | -3.70% | -7.14% | -14.75% | +8.33% | +71.90% | +80.87% | 135M | |
| +2.70% | -5.00% | -8.43% | +5.56% | -30.28% | -54.22% | - | - | - | 130M | |
| +0.21% | +1.69% | -2.24% | +0.42% | +8.09% | +16.18% | +34.36% | +10.57% | -38.80% | 57.97M | |
| +0.45% | -1.02% | -10.59% | -9.09% | -3.35% | -5.78% | +30.32% | -6.34% | +35.35% | 54.61M | |
| +1.03% | +0.71% | +3.14% | -3.18% | +3.64% | +1.75% | +1.19% | -5.26% | +4.23% | 51.21M | |
| Average | +0.34% | -1.21% | +2.16% | -4.76% | +9.81% | -3.64% | -1.10% | -6.42% | +32.49% | 190.44M | |
| Weighted average by Cap. | +0.59% | -0.59% | -3.46% | -0.44% | +15.31% | +1.45% | -1.61% | +2.65% | +43.89% |
- Stock Market
- Stocks
- ATER Stock
- Sector Aterian, Inc.
Select your edition
All financial news and data tailored to specific country editions
